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Abstract
A hotly debated topic in oropharyngeal dysphagia is the Clinical Swallowing Examination’s (CSE) importance 
in clinical practice. That debate can profit from the application of evidence-based medicine’s (EBM) principles 
and procedures. These can guide both appropriate data collection and interpretation as will be demonstrated in 
the present report. The study’s purpose from which data for this report are drawn was to determine the 
relationship among signs elicited by a CSE and aspiration on a subsequent videofluoroscopic swallowing 
examination (VFSE). Sensitivity, specificity; positive and negative predictive values (NPV); likelihood ratios; 
and post-test probabilities for a variety of signs in isolation and in combinations are reported. These data, if 
judiciously selected and interpreted contribute to the clinician’s knowledge about whether to follow a CSE with 
a VFSE and about what to expect if the VFSE is completed. Learning outcomes: (1) Clinicians will learn how to 
use EBM principles in conjunction with clinical assessments of swallowing to enhance patient care. (2) 
Clinicians will learn how to identify combinations of patient signs during he CSE to predict VFSE performance.
John C. Rosenbek, Gary H. McCullough, Robert T. Wertz (2004) "Is The Information About A Test 
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The clinical examination for swallowing (CSE) is overshadowed by two instrumental 
examinations: videofluoroscopy and endoscopy. The reasons are multiple, with a major 
being the assumption that the CSE fails to provide information on the presence or absence 
of aspiration on an instrumented examination. Another is that information on the abnormal 
biomechanics that result in signs of dysphagia and which are critical to treatment planning 
is unavailable from the CSE. It was this study’s purpose to address the first of these reasons: 
the assumption that data from a CSE are only weakly related to aspiration on the 
videofluoroscopic swallowing examination (VFSE). Doing so required a systematic 
approach to the two procedures guided by the principles and procedures of evidence- 
based medicine (EBM) as they have been applied to a variety of other diagnostic tests. 
Indeed the title of this paper is a paraphrased borrowing from Sackett, Richardson, 
Rosenberg, and Haynes (1998): Is the evidence about a diagnostic test important? 
Specifically the question asked in this study is whether results of the CSE are related 
to aspiration on VFSE. It is to be emphasized that predicting aspiration on VFSE is but one 
of the possible reasons for completing a CSE, albeit an important one to a majority of 
clinicians. Therefore, to answer it, selected data from the CSE and VFSE for 60 patients 
made dysphagic by stroke were analyzed. After Sackett et al. (1998), the analyses were: 
true and false negatives and positives, sensitivity and specificity, positive and negative 
predictive values (NPV), positive and negative likelihood ratios, and pre-and post test 
probabilities. 
1. Procedures
1.1. Participants 
Sixty acute stroke patients from two Veteran’s Administration (VA) hospitals and 
one university hospital served as participants. Descriptive data are provided in Table 1. 
Their mean age is 67.8 with a range of 40–96. Fifty-five were male. Mean number of 
days post-onset was 5.98 with a range of 1–42. The majority of these participants were 
within 2 weeks of stroke. Brain imaging, most frequently with computerized 
tomography (CT) confirmed that 44 had suffered a single stroke and 16 had suffered 
two or more strokes. The data on locus of lesion and presence or absence of aspiration 
appear in Table 2. 
Table 1 
Descriptive data on study participants
Variable N Mean Range S.D.
Age in years 60 67.8 40–96 9.94
Days post-onset of CVA 60 5.98 1–42 7.38 
Gender 
Male 55
Female 5 
Table 2 
Lesion localization and presence or absence of aspiration on VFSE 
Localization N Aspiration No aspiration
Cortical 
Right 11 4 7
Left 17 5 12 
Bilat 1 1 
Subcortical 
Right 9 3 6
Left 4 1 3 
Bilat 1 1 
Brainstem 
Right 2 1 1
Left 2 1 1 
Bilat 2 1 1 
Cerebellar 3 1 2
Mixed 5 1 4 
Questionable 3 3 
1.2. Clinical swallowing examination (CSE) 
Each participant received a CSE comprising four sections: history, oral/motor praxis, 
voice, and trial swallows. All items were developed from a survey of clinicians’ 
preferences and practices for evaluating dysphagia (McCullough, Wertz, Rosenbek, & 
Dineen, 1999). All test items reported in this paper meet minimum standards of reliability 
(Kappa significant at P < 0.05) and are summarized in Tables 2–5. Procedures have been 
described previously (McCullough, Wertz, & Rosenbek, 2001) and only a brief summary 
appears here. To allow for calculation of inter- and intra-judge reliability, three experienced 
judges reviewed the medical chart to retrieve history data and not surprisingly reliability 
was high. A variety of verbal and nonverbal tasks were used to elicit oral motor/praxis 
and  voice  performance  and  all  three  judges  working  independently  scored  responses. 
Table 3 
Sensitivity (SENS), specificity (SPEC), positive predictive value (PPV), negative predictive value (NPV), 
positive likelihood ratio (+LR), and negative likelihood ratio (-LR) of history signs for detecting aspiration 
SENS (%) SPEC (%) PPV (%) NPV (%) +LR -LR
1. Patient report 38 79 43 64 1.8 0.78
2. Family report 14 80 44 41 0.64 1.1 
3. Pneumonia 32 92 70 71 4.0 0.74 
4. Poor nutrition 50 76 53 91 2.1 0.66 
5. Feeding tube 36 95 80 72 6.9 0.67 
6. Need suction 5 100 100 65 a 0.95 
7. COPD 23 82 42 65 1.2 0.95 
COPD: chronic obstructive pulmonary disease. 
a 
+LR could not be calculated. 
Table 4 
Sensitivity (SENS), specificity (SPEC), positive predictive value (PPV), negative predictive value (NPV), 
positive likelihood ratio (+LR), and negative likelihood ratio (-LR) of oral motor signs for detecting aspiration 
1. Tongue
SENS (%) SPEC (%) PPV (%) NPV (%) +LR (%) -LR (%)
(a) Strength 50 74 58 72 1.9 0.7 
(b) ROM 36 71 55 66 1.3 0.9 
2. Lips
(a) Strength 27 76 60 66 1.2 1.0 
(b) ROM 84 41 44 82 1.4 0.4
3. Jaw
(a) Strength a a a 61 a a 
(b) ROM (lateral) 38 74 57 67 1.5 0.8
4. Soft palate
(a) Strength 41 71 67 68 1.4 0.8 
(b) Symmetry 50 53 47 67 1.1 1.0 
5. Volitional cough
(a) Strength 70 45 45 68 1.3 0.7 
(b) Qualityb 55 68 59 73 1.7 0.7
6. Pharyngeal gag 91 18 38 86 1.1 0.5
7. Oral apraxia 41 68 58 67 1.3 0.9 
8. Dysarthria 77 55 48 81 1.7 0.4 
9. Intelligibility 73 58 50 79 1.7 0.6 
10. Secretions 50 84 65 74 3.2 0.6 
11. Attends 50 53 47 65 1.1 1.0 
ROM: range of motion. 
a Jaw strength measures could not be calculated due to low numbers of participants with decreased jaw 
strength. 
b Wet vs. dry. 
Table 5 
Sensitivity (SENS), specificity (SPEC), positive predictive value (PPV), negative predictive value (NPV), 
positive likelihood ratio (þLR), and negative likelihood ratio (-LR) of voice signs for detecting aspiration 
SENS (%) SPEC (%) PPV (%) NPV (%) þLR -LR 
Speech 
1. Dysphonia 91 22 40 80 1.2 0.4 
2. Breathy 82 30 41 75 1.2 0.6 
3. Harsh 36 84 40 73 2.2 0.8 
4. Wet 50 78 64 73 2.3 0.6 
5. Resonance 46 81 57 71 0.4 0.7 
Imbalance (sustained AH)
1. Dysphonia 100 27 43 100 1.4 0.0 
2. Breathy 81 37 44 80 1.3 0.5 
3. Wet 50 84 67 76 3.1 0.6 
 
 
Swallowing testing involved the same number and type of boluses used in the video- 
fluoroscopic swallowing examination. The three judges again independently scored 
performance. Their goal was to listen and look for the signs of aspiration and register 
a judgment about its presence or absence. 
 
1.3. Videofluoroscopic swallowing examination (VFSE) 
 
One of the authors, G.M., completed all VFSEs within 24 h of the CSE. The protocol has 
previously been described (McCullough et al., 2001). Each participant received in order: 
four thin liquids, two 5 cc and two 10 cc (50% barium sulfate powder and 50% water) with 
a viscosity of 14 cP; two 5 cc thick liquid swallows (mixture of barium sulfate, water and 
Thick-It) with a viscosity of 187 cP; two 5 cc swallows of applesauce and barium sulfate 
powder (two tablespoons of barium per four ounces of applesauce); and two cookie 
swallows (one-fourth of a Lorna Doone coated with applesauce and barium mixture). Only 
a single judge, G.M., rated the VFSEs within 1 week of their completion and without  
knowledge of CSE results. Twenty-two patients (37%) were judged to have aspirated (see 
Table 2). 
 
 
2. Analysis 
 
Determining if the results of a procedure (e.g., CSE) are useful in detecting a disease or 
condition (e.g., aspiration on VFSE) begins with the construction of a 2 x 2 table. The 2 x 
2 table’s purpose is to allow comparison of the test’s results with the results on a ‘‘gold 
standard.’’ In the analysis to follow, the data to be reported are the number of participants 
who aspirated and who did not aspirate on VFSE and the number of those same participants 
who did and did not have the sign (i.e., wet voice after swallow on the trial swallow portion 
of the CSE). Looking at Fig. 1 in which these data are used to construct the 2 x 2 table will 
make the subsequent discussion easier to follow. These are the data that will be used for all 
subsequent calculations except for the last, when multiple signs (including wet voice after 
swallow) are combined. Other findings from the CSE could have been used as examples 
and a variety of tables will summarize specific calculations, for example, sensitivity and 
specificity and positive and negative predictive values for all reliable data from all four 
parts of the CSE. What follows, however, are calculations for wet voice and aspiration and 
no aspiration on VFSE. 
 
2.1. True and false positives and negatives 
 
In clinical practice one hears frequently about results that are true or false positive or true 
or false negatives. The adjective true has a good connotation and false a bad one. In any 
comparison of a test result with a gold standard, the number of true and false positives and 
negatives is calculated from a 2 x 2 table. Consider wet voice after swallow and aspiration 
on VFSE as displayed in Fig. 1. True positives are the number of participants who had wet 
voice after swallow and who subsequently aspirated on VFSE. That number is recorded in 
cell ‘‘a.’’ Eleven of 60 participants are recorded as true positives. True negatives are the 
 
 
 
 
Fig. 1. Signal detection 2 x 2 contingency table demonstrating sensitivity, specificity, positive predictive value, 
negative predictive value, positive likelihood ratio, and negative likelihood ratio of one clinical/bedside 
swallowing sign (wet voice after swallow) for detecting aspiration. Sensitivity =a/(a +c) = 11/(11 +11) = 
50%; specificity =d/(b + d) = 24/(14 + 24) = 63%; positive predictive value =a/(a + b) = 44%; negative 
predictive value = d/(c + d) = 69%; positive likelihood ratio = sensitivity/(l - specificity) = 0.50/(1 - 0.63) = 
1.4; negative likelihood ratio = (1 - sensitivity)/specificity ¼ 0.8; CSE ¼ clinical swallowing examination; 
VFSE ¼ videofluoroscopic swallowing examination; TP = true positive; FP =false positive; FN = false 
negative; TN ¼ true negative. 
 
number of participants who have normal voice after swallow and who do not aspirate on 
VFSE. That number recorded in cell ‘‘d’’ is 24. False positives (see cell ‘‘b’’) are those 
participants (i.e., 14 of the 60 in this study) who have wet voice but do not aspirate on a 
subsequent VFSE. False negatives (see cell ‘‘c’’) are those participants (i.e., 11 of the 60 in 
this study) who do not have wet voice after swallow but who subsequently aspirate on 
VFSE. Fourteen false positives and 11 false negatives from a sample of 60 seem large but 
taken by themselves these numbers are not as meaningful as they might be. The challenge, 
therefore, is to use these data to calculate more meaningful values. A number of 
calculations are available beginning with sensitivity and specificity. 
 
2.2. Sensitivity and specificity 
 
Sensitivity and specificity are traditional and widely used calculations to determine the 
value of a test. The sensitivity of a clinical sign (e.g., wet voice after swallow evidencing 
aspiration) for detecting a sign on a laboratory measure (e.g., aspiration on the VFSE) is 
defined as the proportion of patients who have the sign (e.g., aspiration on VFSE), who are 
also positive for the clinical sign (e.g., wet voice after swallow). Returning to the 4 x 4 
table, sensitivity is derived by the following equation: a/(a + c) or the number of true 
positives divided by the sum of the true positives and false negatives. Therefore, the 
sensitivity of wet voice after swallow is equal to: 11/(11 +11) or 0.500. This means that 
out of the people in this sample of stroke patients who actually aspirated, 0.500 (or 50%) 
 
 
were also positive for ‘‘wet voice after swallow.’’ High values for sensitivity mean that a 
negative result for the clinical sign should, theoretically, help rule out the diagnosis 
(Sackett et al., 1998). So if sensitivity for ‘‘wet voice after swallow’’ were 95% rather than 
50%, then the lack of a ‘‘wet voice after swallow’’ should help determine that aspiration did 
not occur. In this example, however, the odds are at chance level. 
The specificity of a clinical sign (e.g., wet voice after swallow) is defined as the 
proportion of patients who do not have the sign on the laboratory measure (e.g., aspiration 
on VFSE) who also do not have the clinical sign. In our example, the specificity of the sign 
‘‘wet voice after swallow’’ for detecting aspiration, as confirmed by VFSE, can be defined 
as the proportion of patients who do not aspirate on VFSE who are also judged to not have 
‘‘wet voice after swallow’’ during the clinical exam. Returning to the 2 x 2 table, 
specificity is derived by the following equation: d/(b+d) or the number of true negatives 
divided by the total number of false positives and true negatives. Therefore, the specificity 
of wet voice after swallow is equal to: 24/(14 + 24) or 0.630. This means that 63% of the 
people in this sample of stroke patients who did not aspirate were also negative for ‘‘wet 
voice after swallow.’’ High values for specificity mean that positive results for a clinical 
measure or sign should, theoretically, help rule in the diagnosis. 
So, if the specificity for ‘‘wet voice after swallow’’ were 95% rather than 63%, then we 
could more safely assume that the presence of a wet voice meant that aspiration occurred. 
Sensitivity and specificity for the reliable variables from the history portion of the CSE 
are reported in columns 2 and 3 of Table 3. Similar data for results of oral motor testing are 
summarized in Table 4. Table 5 contains the data for voice testing, and Table 6 contains the 
data for trial swallows. One can look for favorites in those data. Doing so reveals interesting 
findings. Consider gag, thought by many to be an extremely important function to test. As 
can be seen in Table 4, the sensitivity for gag is 91%. This means aspiration is unlikely in a 
person with a normal gag. Specificity, however, is only 18%. Thus the presence of an 
abnormal gag leaves the examiner with little information about aspiration. Gag, therefore, 
depending on its integrity, may be of limited usefulness. Other variables can be evaluated 
similarly. 
‘‘Sensitivity and specificity describe the proportion of positive and negative test results 
in a population in whom we already know who has the disease or not’’ (Go, 1998). This 
 
Table 6 
Sensitivity (SENS), specificity (SPEC), positive predictive value (PPV), negative predictive value (NPV), 
positive likelihood ratio (þLR), and negative likelihood ratio (-LR) of trial swallow signs for detecting 
aspiration 
 
 SENS (%) SPEC (%) PPV (%) NPV (%) +LR -LR 
1. Delayed swallow 48 68 52 72 1.5 0.8 
2. Spontaneous cough 68 82 68 97 3.7 0.4 
3. Wet voice 50 63 45 69 1.4 0.8 
4. Estimate P/A 77 63 57 83 2.1 0.4 
5. 3 ounce swallowa 86 50 39 91 1.7 0.3 
6. Overall rating of dysphagia 91 47 43 90 1.7 0.2 
P/A: penetration/aspiration. 
a Wet voice or spontaneous cough/clear within 1 min. 
requirement of knowing a priori is considered to be a major draw back to these values, as 
we do not typically know who has the disease before testing. Otherwise, there would be no 
reason to test. This point is especially cogent in comparisons of clinical and videofluoro- 
scopic swallowing examinations as the issue is whether or not to follow a clinical 
examination with an instrumented examination such as the VFSE. Of course with the 
data presented in this paper, clinicians have the data to decide, depending on the purpose of 
testing, on the usefulness of a variety of clinical signs. However, other calculations, 
including negative and positive predictive values (PPV) are also available. 
2.3. Positive and negative predictive values 
As used in traditional medicine, the positive predictive value of a clinical sign can be 
defined as the proportion of patients who are positive for that sign who also have a 
particular disease (Go, 1998). In our example, the PPV of the sign ‘‘wet voice after 
swallow’’ for detecting aspiration, as confirmed by VFSE, can be defined as the proportion 
of patients who have a ‘‘wet voice after swallow’’ during the clinical exam who also 
aspirate on VFSE. Using the same 2 x 2 contingency table (see Fig. 1) and the data in our 
four squares representing true and false positives and true and false negatives, PPV is 
derived by the following equation: a/(a + b). In other words the number of true positives is 
divided by the total number true and false positives. Therefore, PPV is equal to: 11/ 
(11 + 14) or 44%. This means that 44% of the individuals status-post stroke who test 
positive for ‘‘wet voice after swallow’’ will aspirate. So, rather than reporting the number 
of people who aspirate and have the clinical sign ‘‘wet voice after swallow,’’ we can switch 
the perspective and report how well a positive clinical sign of ‘‘wet voice after swallow’’ 
predicts aspiration subsequent to stroke. 
As used in traditional medicine, the negative predictive value of a clinical sign can be 
defined as the proportion of patients who are negative for a clinical sign who do not have 
the disease (Go, 1998). In our example, the NPVof the sign ‘‘wet voice after swallow’’ for 
detecting aspiration, as confirmed by VFSE, can be defined as the proportion of patients 
who do not test positive for ‘‘wet voice after swallow’’ during the clinical exam and who 
also do not aspirate. Using the 2 x 2 contingency table (see Fig. 1) and the data in our four 
squares representing true and false positives and true and false negatives, NPV is derived by 
the following equation: d/(c + d). In other words, this is the number of true negatives 
divided by the total number of false and true negatives. Therefore, NPV is equal to: 24/ 
(11 + 24) or 69%. This means that 69% of individuals who are status post stroke and do not 
have a ‘‘wet voice after the swallow’’ will also not aspirate. 
Positive and negative predictive values for all observations and signs are reported in 
columns 4 and 5 of Table 3 through 6. As can be seen in Table 3, the positive predictive value 
of needing suctioning is 100%. In a larger sample this value may be reduced, however, a 
patient requiring suctioning is very likely to aspirate. No other sign has an equal value. 
2.4. Likelihood ratios (LR) 
Another way of using the same data if the evidence from a test is important, is to calculate 
positive and negative likelihood ratios. Both are derived from sensitivity and specificity. The 
 
 
formula for a positive likelihood ratio is +LR ¼ sensitivity/(l - specificity); the formula for 
a negative likelihood ratio is -LR ¼ (1 - sensitivity)/specificity. 
Rather than being expressed  as  decimal  values  or  percent  probabilities,  LRs 
are expressed in the form of how ‘‘likely’’ something is to occur. Thus, instead of 
telling us that someone has a 44% probability of aspirating based on a clinical sign of 
‘‘wet voice after swallow,’’ LRs tell us that the likelihood of a ‘‘wet voice after swallow’’ 
is 1.4 times greater for someone who  aspirates  than  someone  who  does  not.  
+LR ¼ sensitivity/(l - specificity) or 0.50/(1 - 0.63), which equals 1.4. -LR ¼ 
(1 - sensitivity)/specificity or (1 - 0.50)/0.63, which equals 0.8. Thus, according to 
this example, the likelihood of not having a ‘‘wet voice after swallow’’ is 0.8 times more 
likely (meaning less likely) in someone who aspirates than in someone who does not 
aspirate. Likelihood ratios for all results on the CSE are reported in columns 5 and 6 of 
Table 3 through 6. 
 
2.5. Post-test probabilities 
 
Taking the time to calculate LRs can be advantageous for a reason beyond their value. 
For example, a positive likelihood ratio can be used with varying pre-test probabilities to 
help establish post-test probabilities. The issue in this paper is the post-test probability 
that a particular patient will aspirate on a VFSE. When a clinician sees a dysphagic 
patient, he may have a general idea of how likely the patient is to aspirate based on the 
patient’s diagnosis. The clinician, therefore, can establish a ‘‘pre-test probability’’ based 
on that general idea. For  example, using the sensitivity and specificity of  CSE signs 
established for stroke patients in the previous investigation (McCullough et al., 2001), 
the overall pre-test probability of aspiration in a stroke patient is  37%.  All  stroke 
patients, however, are not equally likely  to  aspirate,  therefore  knowing  the  locus  of 
lesion can improve the pre-test probability. If the patient had a brainstem stroke, the 
literature (Horner, Massey, Riski, Lathrop, & Chase 1988) suggests the pre-test 
probability for that patient aspirating is closer to 50%, perhaps higher, depending on 
the area of the brainstem disrupted (Kim, Chung, Lee & Robbins, 2000). Pre-test 
probabilities can be further refined from other research articles or experience in your 
clinical  setting. 
A likelihood ratio, derived from the CSE, may be utilized in conjunction with this 
pre-test probability to establish a post-test probability. Post-test probabilities may be 
derived mathematically (Go, 1998; Sackett, 1985; Sackett et al., 1998) or by using a 
nomogram (see Fig. 2). The mathematical method requires a number of calculations not 
yet described. The first is a calculation of the prevalence. Prevalence is defined 
mathematically as (a + c/(a + b + c + d)). Prevalence in our study is 37%. This value 
is then folded into the formula for pretest odds defined mathematically as prevalence/(l 
- prevalence) or 0.37/(1 - 0.37) ¼ 0.59. The next calculation is of post-test odds 
defined as pre-test odds x likelihood ratio or 0.59 x 1.4 = 0.83. And finally post-test 
probability is equal to post-test odds/(post-test odds + 1). In our example, this yields 83/ 
(0.83 + 1) = 0.45. 
Fortunately, there is a simpler way and that is to use a nomogram (See Fig. 2), which 
uses the pre-test probability and the likelihood ratio plus a straight edge to derive a 
Fig. 2. Nomogram for calculating post-test probabilities from pre-test probabilities and likelihood ratios. 
post-test probability. Based on the fact that 37% of the stroke patients in this sample 
aspirated, we set our pre-test probability at 37%. Place a mark on the left part of the 
nomogram (Fig. 2, the axis labeled ‘‘pretest probability’’) at 37%. Then, because the +LR 
for ‘‘wet voice after swallow’’ is 1.4, we place another mark on the center axis of the 
nomogram (Fig. 2, ‘‘Likelihood Ratio’’) at roughly 1.4. Using a straight edge, we then draw 
a line from the pretest probability to the likelihood ratio and straight through to ‘‘post-test 
probability.’’ Using this method, we can determine that the post-test probability for this 
patient aspirating is about 45%, the same value as that derived mathematically. 
Wet voice after swallow on the CSE, despite its clinical appeal, is less than impressive as 
a sign for predicting aspiration on VFSE. Many of the other findings suffer a similar fate. 
So what is a clinician to do? One viable alternative is to identify combinations of signs that 
increase the power of the CSE to predict VFSE performance. 
 
 
Table 7 
Sensitivity (SENS), specificity (SPEC), positive likelihood ratios (þLR) for select, reliable clinical/bedside 
signs for detecting aspiration 
 
 SENS SPEC +LR 
History 
1. Pneumonia 
 
0.318 
 
0.921 
 
4.025 
2. Poor nutrition 0.500 0.763 2.110 
3. Feeding tube 0.364 0.947 6.870 
4. Need suction 0.048 1.000 – 
Oral motor 
1. Tongue strength 
 
0.500 
 
0.737 
 
0.901 
2. Cough strength 0.700 0.450 1.273 
3. Secretions 0.500 0.842 3.165 
Speech/voice/praxis 
1. Dysphonia 
 
1.000 
 
0.270 
 
1.370 
2. Dysarthria 0.773 0.553 1.729 
Trial swallows 
Spontaneous cough 
 
0.682 
 
0.816 
 
3.707 
Wet voice 0.500 0.632 1.359 
 
2.6. Combining signs 
 
Any of the values previously described can be derived for combinations of signs from the 
CSE. Although one cannot simply add two LRs together to increase likelihood of a positive 
test result, one can calculate LRs from combinations of measures. To illustrate this 
methodology, consider the CSE measures with the best +LRs for detecting aspiration 
(see Table 7). There are four history signs (pneumonia, poor nutrition, feeding tube, need 
suction), three oral motor signs (tongue strength, cough strength, secretions), two signs 
extracted from speech/voice/praxis sections (dysphonia, dysarthria), and two trial swallow 
signs (spontaneous cough, wet voice) which appear better than the other measures in terms 
of +LR. Using these data we can construct a 2 x 2 contingency table to determine the 
sensitivity and specificity for various combinations of these signs within each category of 
the CSE. That number can then be converted into a +LR (+LR ¼ sensitivity/1 - 
specificity). LRs can then be rank ordered (see Table 8). 
If one of four history signs is present, the LR of aspiration is 2.45 times greater than if no 
history signs were present. As the number of positive signs within a category (i.e., history 
signs) increases, the LR increases (one of four = 2.45; two of four = 12.23). Therefore, 
based on these data, if your patient is positive for two of the four history signs, that person 
would be 12 times more likely to aspirate than someone without two of the four history signs. 
LRs for three and four history signs present could not be computed because sensitivity 
reached 1.000, creating an incalculable LR. One can logically assume, however, that having 
even more of these signs present would increase the likelihood of aspiration or, at least, the 
need to rule it out instrumentally. One important point to make here is that combined LRs are 
calculated under different criteria than single measure LRs. For example, Tables 3 and 4 
report that the =LR for ‘‘pneumonia’’ is roughly 4.0. Then, Table 8 reports that the presence 
 
 
Table 8 
Likelihood ratios for combined clinical/bedside signs and nomogram for calculating post-test probability 
 
CSE signs present from four categories Likelihood ratio 
History 2/4 12.23 
Signs present from all categories 8.28 
History 1/4 8.26 
Oral motor 1/3  
Trials swallows 1/2  
History 1/4 6.17 
Trial swallows 1/2  
History 1/4 3.97 
Oral motor 1/3  
Trial swallows 1/2 2.68 
History 1/4 2.45 
Oral motor 1/3 2.18 
Dysarthria or dysphonia  
Oral motor 1/3 1.96 
Dysarthria or dysphonia 1.32 
 
of one of four of these best history signs only provides a =LR of 2.45. How is that possible? It 
is possible because in the latter example (Table 8) the presence or absence of pneumonia is 
considered in conjunction with the presence or absence of three other measures. It is a very 
different analysis. Whether more valuable information can be gained from individual 
measures or groups of measures remains to be tested; however, since a CSE is comprised 
of a variety of tasks, one might expect that analyses utilizing more than one variable could 
prove beneficial. On the other hand, if a clinician assesses swallowing in a patient with a 
history of pneumonia, the red flag may well be large enough and bold enough to warrant a 
complete regiment of available assessment tools. 
The same methodology for combining signs can be used with oral motor signs, speech 
praxis/voice, or trial swallows. Moving up from the bottom of Table 8, we observe that if an 
individual has dysarthria or dysphonia subsequent to stroke, they are only 1.32 times more 
likely to aspirate, meaning that the presence of either of these two signs may be of limited 
utility. Other studies have shown stronger relationships between voice disorders and 
aspiration post stroke (Daniels et al., 1998; Horner et al., 1988). If one of three of the oral 
motor signs is present, the patient is 1.96 times more likely to aspirate. At this point, signs 
from different categories can be mixed and matched for analysis. For example, the presence 
of dysarthria or dysphonia in combination with oral motor signs does indicate an increased 
risk of aspiration (2.18) over the presence of either of the other signs in isolation (1.32 and 
1.96), though not markedly. The presence of one of the four history signs along with one of 
the four oral motor signs is much more informative (3.97 times more likely to aspirate) as is 
the combination of one of four history signs with one of the two trial swallow signs (6.17 
times more likely to aspirate). If one sign from each of the history, oral motor, and trial 
swallow signs is present, the likelihood of aspirating post-stroke increases to 8.26. At least 
one sign present from each of the four categories does not change the results substantively 
(8.28), which, again, indicates limited utility for measuring dysarthria or dysphonia 
according to our results. 
3. Conclusions
Evidence-based practice depends upon combining clinical experience and insight with 
the best available data about the features of a particular test for a clinician’s specific 
purpose. Thus there will be no universal answer to the question: Is the evidence about a 
diagnostic test important? Clinical experience, insight and purposes of testing differ, and 
nowhere, perhaps, is a universal answer more unlikely than in dysphagia. Training and 
clinical experience are highly variable and data often go unnoticed. In addition, the reasons 
for using the CSE differ from clinician to clinician, institution to institution, patient to 
patient, and even from time to time for the same patient. The data in this paper may be 
useful to the clinician charged with determining the probability that a stroke patient 
presenting with a particular history or set of signs on a CSE will aspirate if clinical testing is 
followed by a VFSE. It is to be recalled that only 60 stroke subjects contributed the data. 
Data analysis from a replication with a larger sample is under way. Other work with the 
CSE and VFSE needs to be done. Perhaps foremost is the need to determine if the evidence 
provided by the CSE can define the biomechanical abnormalities responsible for signs of 
dysphagia, including, but certainly not limited to, aspiration. In the interim it is critical that 
the CSE not be relegated to the status of a screening tool. It is far too powerful. 
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Appendix A.  Continuing education 
1. The purpose of this paper is to:
(a) suggest that a clinical examination of swallowing is superior;
(b) suggest that a clinical examination of swallowing is a waste of time;
(c) describe how clinicians can use EBM principles in conjunction with clinical
assessments of swallowing to enhance patient care; 
(d) discredit the use of 2 x 2 contingency tables in statistical analyses; 
(e) none of the above. 
2. High values for sensitivity mean that:
(a) a negative result for the clinical sign should, theoretically, help rule out the
diagnosis; 
(b) a positive result for the clinical signs should help rule in the diagnosis; 
(c) the sign is predictive of aspiration; 
(d) the patient might easily get his feelings hurt; 
(e) none of the above. 
3. Likelihood ratios can be derived from:
(a) 2 x 2 contingency tables;
(b) sensitivity and specificity; 
(c) hard, honest work; 
(d) a and b; 
(e) none of the above. 
4. Likelihood ratios:
(a) can be derived for combinations of measures;
(b) can be combined with clinician-based pre-test probabilities to derive a post-test
probability; 
(c) indicate the ‘‘likelihood’’ that something could occur; 
(d) a and b; 
(e) all of the above. 
5. Evidence-based practice depends upon:
(a) clinical experience;
(b) insight with the best available data about the features of a particular test;
(c) knowledge regarding the principles of EBM;
(d) a and b;
(e) all of the above.
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